Skip to main content

TAPID Collaboration

This webpage includes information about:

TAPID collaboration  | TAPID meetings | TAPID publications | TAPID members

TAPID collaboration

TAPID (Transplantation and Primary Immunodeficiency [PID]) is an important and ongoing expert collaboration facilitated by ASCIA, between clinical immunologists, transplant physicians and international experts.  A/Prof Theresa Cole is the TAPID coordinator and ASCIA President. TAPID members and publications are listed below. 

The main objective of TAPID is to enable complex PID and transplantation cases to be peer reviewed and discussed in a confidential expert forum and to publish guidelines. Three publications have been developed as a result of this project and it is our intention to develop more publications in future. 

TAPID meetings

The TAPID collaboration was initiated in May 2013, and since then there have been in-person meetings in February 2014, May 2017, May 2018, May 2019, April 2023 and May 2024.

A TAPID Case Discussion Form needs to be completed for every deidentified case to be discussed at TAPID meetings and a template form is available here: 

pdfTAPID Case Discussion Form96.15 KB

The final TAPID Zoom meeting for this year is on 18th December 2024

TAPID Zoom meetings will continue to be held in 2025 from 5.30-6.30pm AEDT or AEST on the 3rd Wednesday of each month, except in May. 

The following schedule includes meetings in April, August and October which will focus on adult cases and an in-person meeting in May:

15th January 2025
19th February 2025
19th March 2025
16th April 2025 - Focus on adult cases
Saturday 24th to Sunday 25th May 2025 - In person TAPID meeting, Larwill Hotel, Melbourne VIC Australia
18th June 2025  
16th July 2025
20th August 2025 - Focus on adult cases
17th September 2025
15th October 2025 - Focus on adult cases
19th November 2025
17th December 2025
 

TAPID publications

The following publications are included in the ASCIA immunodeficiency reference list :

Richards, S., Gennery, A.R., Davies, G., Wong, M., Shaw, P.J., Peake, J., Fraser,C., Gray, P., Brothers, S., Sinclair, J., Prestidge, T., Preece, K., Quinn, P., Ramachandran, S., Loh, R., McLean-Tooke, A., Mitchell, R., Cole, T., on behalf of ASCIA Transplantation and Primary Immunodeficiency (TAPID) group. (2020). Diagnosis and management of severe combined immunodeficiency in Australia and New Zealand. Journal of Paediatrics and Child Health, 56, 1508–1513. https://onlinelibrary.wiley.com/doi/10.1111/jpc.15158

ASCIA-TAPID Consensus Guideline: Diagnosis, management and transplantation of severe combined   immunodeficiency in Australia and New Zealand. 2019 www.allergy.org.au/hp/papers/ascia-guidelines-scid-tapid  This Guideline includes information in the published Position Paper (see above) and additional information about transplantation. It is available on the ASCIA website www.allergy.org.au/hp/hp/papers/ascia-guidelines-scid-tapid

Cole, T., McLean‐Tooke, A., Loh, R., Quinn, P., Peake, J., Sinclair, J., Gray, P., Wong, M., Smith, J., Davies, G., Gennery, A., Smart, J. (2018). ASCIA transplantation and primary immunodeficiency (TAPID) project. Internal Medicine Journal, 48, Issue S6. https://onlinelibrary.wiley.com/doi/10.1111/imj.48_14077

TAPID members

There are currently 218 TAPID members, including 133 ASCIA members.

 

Webpage updated December 2024